WuXi Biologics reports April share movements, option exercises

WuXi Biologics (HKEX:2269) reported a net increase of 9,114,074 in issued ordinary shares for April 2025, according to a new submission filed with the Hong Kong Stock Exchange on May 7, 2025. This increase stems from the exercise of share options under various pre-IPO schemes, raising a total of USD1,585,207.22 in funds. The company noted exercises under schemes dated January 7, 2016, March 28, 2016, August 10, 2016, November 11, 2016, March 15, 2017, and May 12, 2017. Simultaneously, the company continues its share repurchase program, with 9,509,500 and 51,030,000 shares repurchased for cancellation but not yet cancelled. At month-end, authorized/registered share capital remains at 6,000,000,000 shares, valued at USD50,000.